Molecular Profiling
Aimed at pathologists and oncologists, this unbranded leave behind focuses on the importance of using broad molecular profiling for mNSCLC (metastatic non-small cell lung cancer) patients. The visual challenge was to crate a unique look that avoids the brand colors and fonts of two different treatments as well as appearing different from the Novartis lung portfolio look.